Oncology Medical News about Myelodysplastic Syndromes Myelodysplastic-Myeloproliferative Diseases

Become a Member Today!
Register

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. Recommendations on the use of 18F-FDG PET in oncology

3. Taxane-based combinations as adjuvant chemotherapy of early breast cancer: a meta-analysis of randomized trials

4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer

5. Sentinel node biopsy is important in mastectomy for ductal carcinoma in situ

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Effect of lenalidomide therapy on hematopoiesis of patients with myelodysplastic syndromes associated with chromosome 5q deletion
Haematologica, 09/25/09

Ximeri M et al. – The beneficial effect of lenalidomide in lower risk MDS patients with del(5q) is associated with significant increase in the proportion of BM erythroid precursor cells and in the frequency of clonogenic progenitor cells, substantial improvement in the hematopoiesis supporting potential of BM stroma and with significant alterations in the adhesion profile of BM CD34+ cells.

<< Previous
Risk of bleeding with vascular endothelial growth factor receptor...

Next >>
Review role of topotecan in gynaecological cancers: Current...

The role of azacitidine in the management of myelodysplastic syndromes (MDS)
Cancer Management and Research, 10/13/09 Relevance Score: 87%

Prognostic molecular markers in myelodysplastic syndromes
Expert Review of Hematology, 10/22/09 Relevance Score: 81%

Relationship of differential gene expression profiles in CD34+ myelodysplastic syndrome marrow cells to disease subtype and progression
Blood, 10/09/09 Relevance Score: 80%

Clinical activity of laromustine (Onrigin) in hematologic malignancies
Expert Review of Hematology, 10/22/09 Relevance Score: 79%

Multicenter validation study of a transplantation-specific cytogenetics grouping scheme for patients with myelodysplastic syndromes
Bone Marrow Transplantation, 10/01/09 Relevance Score: 79%